IDSA Offers New Guidelines For Complicated Urinary Tract Infections 

IDSA Offers New Guidelines For Complicated Urinary Tract Infections 

Recently, the Infectious Disease Society of America (IDSA) released the first guidelines on management and treatment of complicated urinary tract infections (cUTIs). The evidence-based guidelines include practical advice for clinicians who manage patients with cUTIs in outpatient settings. For example, clinicians can view the UTI and cUTI classifications intended to guide treatment (not diagnosis) as well as recommendations on the selection and duration of definitive antibiotic therapy for cUTI. UTI is common: IDSA notes that …

Read More
Oral Drug Offers Options For Complicated UTI

Oral Drug Offers Options For Complicated UTI

The Food and Drug Administration (FDA) this month approved tebipenem pivoxil for adults with complicated urinary tract infections (cUTIs), including pyelonephritis, in patients who have limited or no alternative oral treatment options. Marketed as Utebzi, it is one of the more significant antibiotic approvals in recent years because it is the first oral carbapenem antibiotic available in the United States, according to manufacturer GSK. Until now, carbapenems (eg, ertapenem, meropenem, and imipenem) have generally required …

Read More
Log In